EMD vs MAP

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

EMD

EMYRIAL FPO [EMD]

51MEDIUM

MAP

MICROBA FPO [MAP]

51MEDIUM

Score Breakdown

EMD MAP
Technical
47
38
Catalyst
52
50
Sentiment
50
50
Fundamental
69
65
Momentum
76
41
Risk Gate
45
50

Key Metrics

EMD Metric MAP
$29.0MMarket Cap$42.6M
945KAvg Volume (20d)112K
N/AShort InterestN/A
$0.07852-Week High$0.230
$0.02152-Week Low$0.069
+2.8%Daily Change+4.5%
$0.037Entry Price$0.070
-58.6%ROE-60.0%
-198.5%Profit Margin-132.5%

Active Signals

EMD Signals

●RSI is looking oversold — historically a spot where stocks tend to bounce
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Sitting near support — this level has held before and could attract buyers again
●Took a hit — down 14.0% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (11 quarters)
●Moderate P/S ratio (12.7x)

MAP Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Took a hit — down 10.3% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (3 quarters) - dilution risk
●4C filed 2026-01-28

Ask Scout AI to compare EMD and MAP in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
EMD Full Analysis → MAP Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).